TACT | Profound Medical

Posts

TACT Pivotal Clinical Trial of TULSA-PRO®: All Primary Efficacy and Safety Endpoints, and Key Secondary Endpoints Achieved

April 5, 2019/in News /by ProfoundMarketing

Head Office

Profound Medical Corp.,
2400 Skymark Avenue,
Unit #6, Mississauga, ON L4W 5K5, Canada

T: 647.476.1350
F: 647.847.3739
info@profoundmedical.com

Cookie and Privacy Settings

How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

Google Analytics Cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visist to our site you can disable tracking in your browser here:

Click to enable/disable google analytics tracking.

Other external services

We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Click to enable/disable google webfonts.

Google Map Settings:

Click to enable/disable google maps.

Vimeo and Youtube video embeds:

Click to enable/disable video embeds.

Posts

TACT Pivotal Clinical Trial of TULSA-PRO®: All Primary Efficacy and Safety Endpoints, and Key Secondary Endpoints Achieved

News

510k Clearance for TULSA-PRO

NEW EUROPEAN PATIENT WEBSITE

Analyst & Investor Day: Recap

Careers & Training

Head Office